April 6, 2017
For Medicare, which accounted for 29% of national retail pharmaceutical spending in 2015, average per capita costs in the Part D prescription drug program are projected to increase annually by 5.8% between 2015 and 2025, faster than the 2.4% average annual rate of growth in per capita costs between 2007. This increase will affect both...
Read More